2nd Quarter - Report

ALLIANCE FOR AGING RESEARCH for ALLIANCE FOR AGING RESEARCH

Firm
Client
Income
—
Expenses
$120,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

-H.R. 3701 the Family Vaccine Protection Act -Food and Drug Administration's Covid Vaccine Schedule Framework -Department of Health and Human Services' Reorganization -H.R. 1 the One Big Beautiful Bill Act -H.R.3164 - Ensuring Community Access to Pharmacist Services Act -Older Americans Act

LobbyistCovered position, as disclosed
SCOTT FREY Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy
ADINA ROSE LASSER New —

Contacted: Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (119th), H.R. 3164 (119th), H.R. 3701 (119th)

Medicare/Medicaid MMM

-Implementation of Medicare Part D beneficiary affordability provisions -Nursing home quality measures -Implementation of the Medicare Direct Negotiation Program -Utilization management reform in Medicare -Anti-obesity medications -Medicaid and the Supplemental Nutrition Assistance Program (SNAP) -Osteoporosis provisions of the Physician Fee Schedule -Essential health benefits

LobbyistCovered position, as disclosed
SCOTT FREY New Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy
ADINA ROSE LASSER —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

-FY26 report language for the Food and Drug Administration -FY26 report language for the Medicare Program -FY26 report language for the Medicare Prescription Payment Plan -FY26 NIH funding -Ensuring appropriated funds are spent and available to Agencies

LobbyistCovered position, as disclosed
SCOTT FREY Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy
ADINA ROSE LASSER —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

-Tariffs on imported medicines

LobbyistCovered position, as disclosed
SCOTT FREY Deputy Commissioner for Legislation and Congressional Affairs -- SSA, Chief of Staff -- SSA, Senior Strategic Advisor -- Office of National Drug Control Policy
ADINA ROSE LASSER —

Contacted: Commerce, Dept of (DOC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.